Press release
Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market Revenue Growth Predicted by 2021
A paradigm shift has been observed with respect to the development of effective therapies involving the use of complementary drug combinations. The main focus of such therapies is to target all the tumor components and impair their function. Tyrosine kinase receptors, mitochondria and microtubule networks are some of the most common targets of cancer cells. This novel approach helps in elucidating the effects of therapeutic combination on each tumor component and results in unveiling of new anti-cancer mechanisms. These anti-cancer mechanisms in turn pave the path for development of new drugs and strategies to tackle with the condition.To get the view of full report @ http://www.persistencemarketresearch.com/market-research/multitargeted-therapies-promiscuous-drugs-combination-therapies-market.asp
Combination therapies are used against complex disorders that have multiple causes along with multiple targets and many small molecule drugs are capable of addressing multiple targets. Multitargeted therapies is the emerging discipline resulting from the combination of chemogenomics and network biology. The market for multitargeted therapies exhibits impressive growth due to effective treatment options, use of small molecule drugs effective against multiple targets and rise in the number of patients suffering from complex diseases such as cancer.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/5567
The market for multitargeted therapies can be segmented on the basis of the molecules used in the treatment and novel approaches towards development of novel combination therapies against multiple targets. Multitargeted protein kinase inhibitors are effective in treating chronic myelogenous leukemia. Synthetic lethality results from the combination of mutations in two or more genes leading to cell death. This approach is adopted to develop targeted therapies in order to reduce the off-target effects due to use of chemopreventative drugs and chemotherapies.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/5567
The major factors driving the growth of the market are constant rise in the number of cancer patients worldwide in conjunction with increasing preference for effective treatment options. In addition, introduction of novel drugs and technological advances will further fuel the market growth. On the contrary, prolonged and tedious development phase followed by high costs of drug development process are some of the factors that might restrain the growth of the market.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market Revenue Growth Predicted by 2021 here
News-ID: 559219 • Views: …
More Releases from Persistence Market Research
Polyester Medical Films Market to Reach US$ 2.9 Billion by 2032 - Persistence Ma …
The global polyester medical films market is evolving rapidly, driven by the rising demand for advanced medical devices, diagnostic applications, and innovative packaging solutions. Polyester medical films have become a preferred material in healthcare because of their excellent strength, clarity, chemical resistance, and biocompatibility. As the healthcare sector continues to expand globally, these films play a crucial role in improving product performance, shelf life, and patient safety.
Get a Sample PDF…
Europe Biostimulants Market to Hit US$3.1 Billion by 2032 Driven by Sustainable …
The Europe Biostimulants Market is witnessing remarkable growth, driven by increasing adoption of sustainable agricultural practices, the growing emphasis on organic farming, and rising awareness about crop productivity enhancement through natural solutions. According to the latest study by Persistence Market Research, the market is valued at US$1.4 billion in 2025 and is projected to reach US$3.1 billion by 2032, expanding at a robust CAGR of 12.4% during the forecast period.…
Nanomaterials Market Valued at US$ 22.1 Billion in 2025, Poised to Reach US$ 69. …
The nanomaterials market has entered a phase of accelerated commercialization, driven by technological maturity and growing demand across sectors. The market's rapid expansion is supported by rising investments in research and development, improved synthesis techniques, and the ability to mass-produce high-quality nanomaterials at reduced costs.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33646
By 2025, the market will reach an estimated valuation of…
Mycotoxin Testing Market Value to Reach US$ 3,268.6 Mn by 2032 Driven by Food Sa …
The global mycotoxin testing market is witnessing robust growth, driven by the increasing need for food safety and quality assurance across agricultural and food production sectors. Valued at US$ 2,145.3 million in 2025, the market is projected to reach approximately US$ 3,268.6 million by 2032, expanding at a steady compound annual growth rate (CAGR) of 6.2% during the forecast period (2025-2032). This growth is primarily attributed to the rising awareness…
More Releases for Multitargeted
ALK-positive Non-Small Cell Lung Cancer Pipeline: Companies Advancing Targeted T …
The therapeutic landscape for ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC), a genetically defined subset of lung cancer driven by ALK gene rearrangements, is undergoing a significant transformation. Biopharmaceutical companies are shifting focus from traditional chemotherapy to precision medicine approaches that directly inhibit ALK-driven oncogenic signaling. With multiple generations of ALK inhibitors now available and resistance mechanisms emerging, the spotlight is on next-generation inhibitors, combination regimens, and CNS-penetrant therapies designed…
Liver Cancer Drug Market - A Comprehensive Study by Key Players: Eisai, Exelixis …
Archive Market Research Released the latest study on Global Liver Cancer Drug Market Growth Outlook 2024-2032 provides an opportunity to better understand details about fundamental restructuring and growth prognosis in Online Apparel Market. This study offers current relevant facts and correlations and elaborates long-term, sustainable strategic and operative suggestions taken up by leading and emerging manufacturers. The sector faces an unprecedented change with regard to the far-reaching effects that it…
Pheochromocytoma Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updat …
DelveInsight's, "Pheochromocytoma Pipeline Insight, 2023," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Pheochromocytoma pipeline landscape. It covers the Pheochromocytoma pipeline drug profiles, including Pheochromocytoma clinical trials and nonclinical stage products. It also covers the Pheochromocytoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
In the Pheochromocytoma Pipeline Report,…
Renal Cell Carcinoma Market Set to Experience Unprecedented Growth During the Fo …
As per DelveInsight, the Renal Cell Carcinoma Market is anticipated to evolve immensely in the coming years owing to the rise in the healthcare spending across the world, the increase in the number of cases of Renal Cell Carcinoma, and the launch of new therapies in the market.
DelveInsight's "Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted…
Cattle Encephalon Glycoside and Ignotin Injection Market Size, Share 2022, Impre …
The global cattle encephalon glycoside and ignotin injection market is anticipated to grow at a CAGR of 3.4% during the forecast period (2022-2028).
Cattle encephalon glycoside and ignotin injection has been widely used in the treatment of central and peripheral nerve injuries. According to WHO, Dementia is a condition in which cognitive performance deteriorates beyond what would be expected as a result of normal biological aging. Dementia is not a…
Fecal Analyzer Market Growth Is Driven By Heska Corporation , AVE Science and Te …
A report by The Insight Partner's on the Fecal Analyzer Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market by monitoring the strengths and weaknesses of prominent contributors and their key products.
The fecal analyzer market was valued at US$ 657.44million in 2019and is projected to reach US$ 842.48…
